CLIFTON, NJ
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)CURE BREAST CANCER FOUNDATION INC, founded in 2007, is a small nonprofit in the Diseases & Disorders sector that reported $516K in total revenue in fiscal year 2023. Revenue decreased 7% compared to the prior year. The organization ran a surplus of $359K, a strong 70% operating margin.
CURE BREAST CANCER FOUNDATION, INC. WAS ESTABLISHED AND IS TO BEOPERATED EXCLUSIVELY TO FURTHER CHARITABLE AND SCIENTIFIC PURPOSES. THE FOUNDATION WILL RAISE FUNDS FROM FUNDRAISING EVENTS SUCH AS GOLF OUTINGS AND OTHER FUNDRAISING EVENTS, INVESTMENT INCOME AND CONTRIBUTIONS FROM INDIVIDUALS AND THE BUSINESS COMMUNITY. THE FOUNDATION WILL MAKE GRANTS TO SUPPORT ACTIVITIES AND PROJECTS RELATING TO THE CAUSES, PREVENTION, TREATMENT AND CURE OF BREAST CANCER, SUCH AS RESEARCH, DRUG TRIALS AND OTHER MEDICAL AND/OR SCIENTIFIC ACTIVITIES AND PROJECTS.
ALBERT EINSTEIN COLLEGE OF MEDICINE:STUDYING THE RELATIONSHIP BETWEEN BONE METABOLISM AND BREAST CANCER. A PAPER DESCRIBING THE RELATIONSHIPS BETWEEN THE FUNCTION OF BONE-FORMING CELLS AND BREAST...
ALBERT EINSTEIN COLLEGE OF MEDICINE:STUDYING THE RELATIONSHIP BETWEEN BONE METABOLISM AND BREAST CANCER. A PAPER DESCRIBING THE RELATIONSHIPS BETWEEN THE FUNCTION OF BONE-FORMING CELLS AND BREAST CANCER BIOLOGY IS SOON TO BE PUBLISHED. THIS WORK RELATES TO BOTH BREAST CANCER AND OSTEOPOROSIS, TWO COMMON PROBLEMS IN POST-MENOPAUSAL WOMEN THROUGHOUT THE WORLD.
BREAST CANCER RESEARCH:GRANTS ARE GIVEN TO ORGANIZATIONS TO BE USED FOR RESEARCH ON A CURE FOR PATIENTS WITH BREAST CANCER AT THE MEMORIAL SLOAN KETTERING CANCER CENTER AS WELL AS OTHER NATIONAL AND...
BREAST CANCER RESEARCH:GRANTS ARE GIVEN TO ORGANIZATIONS TO BE USED FOR RESEARCH ON A CURE FOR PATIENTS WITH BREAST CANCER AT THE MEMORIAL SLOAN KETTERING CANCER CENTER AS WELL AS OTHER NATIONAL AND INTERNATIONAL BREAST CANCER RESEARCH ORGANIZATIONS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $516,468 | $556,648 | -0.1% |
| Expenses | $157,280 | $385,860 | -0.6% |
| Net Income | $359,188 | $170,788 | +1.1% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| CARLY ABRAMSON | PRESIDENT | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| LAUREN MIRMAN | VP AND TRUSTEE | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| HEATHER SYMONS | VP AND TRUSTEE | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| ANDREW ABRAMSON | TREASURER & SECRETARY | 4.00 |
Officer
Director
|
$0 | $0 | $0 |
| DRLARRY NORTON | SCIENTIFIC ADVISOR | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $516,468 | $157,280 | $3,647,067 | $359,188 |
| 2022 | $556,648 | $385,860 | $3,242,235 | $170,788 |
| 2021 | $595,685 | $356,048 | $3,130,313 | $239,637 |
| 2020 | $484,807 | $404,445 | $2,851,431 | $80,362 |
| 2019 | $620,382 | $312,374 | $2,734,860 | $308,008 |
| 2018 | $562,643 | $53,936 | $2,406,894 | $508,707 |
Compare CURE BREAST CANCER FOUNDATION INC with other nonprofits in New Jersey and across the country.